Key facts
- It has raised $28.0M; the latest was Later Stage VC ($14.0M) in Sep 2025.
- Notable investors include MedTech Innovator, Samsung NEXT Ventures, Samsung Venture Investment, IBB Ventures, Jindong Investment Group — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for DiaMonTech
- ·The full record, as it builds
Funding rounds
No funding rounds for DiaMonTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DiaMonTech
Developer of a wearable device designed to help people with diabetes for the non-invasive measurement of glucose. The company's device uses an invisible infrared light beam and non-invasively measures blood glucose without finger pricking, a drop of blood, or a test strip, providing patients with the precise measurement of relevant blood parameters.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2015
- Employees
- 34
- Website
- diamontech.de/
- Ownership
- Privately Held (backing)
DiaMonTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DiaMonTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DiaMonTech in its N-PORT filings yet. We sweep new filings monthly.